Abstract Epstein–Barr virus (EBV)-positive mucocutaneous ulcers (EBVMCUs) are localized
mucosal or cutaneous ulcers caused by the proliferation of EBV-infected B cells in patients …

Epstein-Barr virus mucocutaneous ulcer (EBVMCU) was first described by Dojcinov et al. in
2010 as a lymphoproliferative disorder presenting with a circumscribed cutaneous or …

Epstein-Barr virus–positive mucocutaneous ulcer is a newly recognized clinicopathological
entity among mature B-cell neoplasms according to the 2016 revision of the World Health …

Immunodeficiency-associated lymphoproliferative disorders (IA-LPDs) constitute a diverse
range of conditions including posttransplant lymphoproliferative disorders, other iatrogenic …

Background Oral ulcers represent a full thickness loss of the mucosal epithelium leading to
exposure of the submucosal connective tissue. These are common and usually self-limited …

1. Gabriel J, McGovern A, Robinson S, et al. A systematic study comparing aspirate versus
trephine for quantifying plasma cell infiltration in newly-diagnosed myeloma. Br J Haematol …

A60-year-old woman came to the Oral and Maxillofacial Pathology Specialty Care Unit at the
St. Louis Dental Center in St. Louis, Missouri, with a painful ulceration on the right buccal …

Epstein–Barr virus (EBV) may cause a wide spectrum of symptomatology in humans ranging
from asymptomatic upper respiratory tract infection to infectious mononucleosis and in more …

Sources of immune deficiency and dysregulation (IDD) are being increasingly recognized
and defined, as are IDD-related B-cell lymphoproliferative lesions and lymphomas occurring …

EBV positive mucocutaneous ulcer (EBVMCU) is a newly recognized clinicopathologic entity
in the 2017 World Health Organization (WHO) classification. Patients frequently present with …